LARGE B-CELL LYMPHOMA

Clinical trials for LARGE B-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new LARGE B-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

New CAR-T therapy shows promise for Hard-to-Treat blood cancers

Disease control Ongoing

This study tests a new treatment called rapcabtagene autoleucel (YTB323) for adults with certain blood cancers like chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), and acute lymphoblastic leukemia (ALL). The treatment u…

Matched conditions: LARGE B-CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 29, 2026 01:36 UTC

LARGE B-CELL LYMPHOMA

Get alerted when new LARGE B-CELL LYMPHOMA trials appear

New CAR-T therapy shows promise for Hard-to-Treat blood cancers